U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
EQUINE THYMOCYTE IMMUNE GLOBULIN
Common Name English
ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE)
WHO-DD  
Preferred Name English
ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN, EQUINE
Common Name English
ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN, EQUINE [JAN]
Common Name English
LYMPHOCYTE IMMUNE GLOBULIN ANTI-THYMOCYTE GLOBULIN (EQUINE)
Common Name English
ANTI-THYMOCYTE GLOBULIN EQUINE NOS
Common Name English
HORSE ATG
Common Name English
HORSE ANTI-THYMOCYTE GLOBULIN
Common Name English
Equine antithymocyte globulin
Common Name English
Antilymphocyte immunoglobulin (horse) [WHO-DD]
Common Name English
ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN,EQUINE [JAN]
Common Name English
EQUINE ANTI-THYMOCYTE GLOBULIN
Common Name English
Antithymocyte immunoglobulin (horse) [WHO-DD]
Common Name English
HATG
Code English
Horse antithymocyte globulin
Common Name English
Classification Tree Code System Code
WHO-ATC L04AA03
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
NCI_THESAURUS C2701
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
NCI_THESAURUS C278
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
WHO-VATC QL04AA03
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
NDF-RT N0000184163
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
Code System Code Type Description
RXCUI
973
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
NDF-RT
N0000007920
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY Immunoglobulins [Chemical/Ingredient]
FDA UNII
475247QF1Z
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108981
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
EVMPD
SUB12913MIG
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
ALTERNATIVE
RXCUI
91601
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
NDF-RT
N0000020023
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY Antibody-Surface Protein Interactions [MoA]
EVMPD
SUB12912MIG
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
DAILYMED
475247QF1Z
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
NDF-RT
N0000009689
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY Increased T Lymphocyte Destruction [PE]
RXCUI
1011
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
ALTERNATIVE RxNorm
NDF-RT
N0000178327
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY Lymphocyte Function Alteration [PE]
SMS_ID
100000090143
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
DRUG BANK
DB09312
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY
NCI_THESAURUS
C80824
Created by admin on Tue Apr 01 20:36:31 GMT 2025 , Edited by admin on Tue Apr 01 20:36:31 GMT 2025
PRIMARY